Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-?) and is used to treat autoimmune diseases.
This report studies the global Infliximab and biosimilar market status and forecast, categorizes the global Infliximab and biosimilar market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).
The major manufacturers covered in this report
Janssen Biotech
Merck and Co.
Pfizer
Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan
Southeast Asia
India
We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Infliximab
infliximab-dyyb
infliximab-abda
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Crohn's Disease
Pediatric Crohn's Disease
Ulcerative Colitis
Rheumatoid Arthritis
Ankylosing Spondylitis
Psoriatic Arthritis
Plaque Psoriasis
The study objectives of this report are:
To analyze and study the global Infliximab and biosimilar capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Infliximab and biosimilar manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Infliximab and biosimilar are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Infliximab and biosimilar Manufacturers
Infliximab and biosimilar Distributors/Traders/Wholesalers
Infliximab and biosimilar Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Infliximab and biosimilar market, by end-use.
Detailed analysis and profiles of additional market players.
Table of Contents
Table of Contents
Global Infliximab and biosimilar Market Research Report 2018
1 Infliximab and biosimilar Market Overview
1.1 Product Overview and Scope of Infliximab and biosimilar
1.2 Infliximab and biosimilar Segment by Type (Product Category)
1.2.1 Global Infliximab and biosimilar Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Infliximab and biosimilar Production Market Share by Type (Product Category) in 2017
1.2.3 Infliximab
1.2.3 infliximab-dyyb
infliximab-abda
1.3 Global Infliximab and biosimilar Segment by Application
1.3.1 Infliximab and biosimilar Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Crohn's Disease
1.3.3 Pediatric Crohn's Disease
1.3.4 Ulcerative Colitis
1.3.5 Rheumatoid Arthritis
1.3.6 Ankylosing Spondylitis
1.3.7 Psoriatic Arthritis
1.3.8 Plaque Psoriasis
1.4 Global Infliximab and biosimilar Market by Region (2013-2025)
1.4.1 Global Infliximab and biosimilar Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Infliximab and biosimilar (2013-2025)
1.5.1 Global Infliximab and biosimilar Revenue Status and Outlook (2013-2025)
1.5.2 Global Infliximab and biosimilar Capacity, Production Status and Outlook (2013-2025)
2 Global Infliximab and biosimilar Market Competition by Manufacturers
2.1 Global Infliximab and biosimilar Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Infliximab and biosimilar Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Infliximab and biosimilar Production and Share by Manufacturers (2013-2018)
2.2 Global Infliximab and biosimilar Revenue and Share by Manufacturers (2013-2018)
2.3 Global Infliximab and biosimilar Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Infliximab and biosimilar Manufacturing Base Distribution, Sales Area and Product Type
2.5 Infliximab and biosimilar Market Competitive Situation and Trends
2.5.1 Infliximab and biosimilar Market Concentration Rate
2.5.2 Infliximab and biosimilar Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Infliximab and biosimilar Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Infliximab and biosimilar Capacity and Market Share by Region (2013-2018)
3.2 Global Infliximab and biosimilar Production and Market Share by Region (2013-2018)
3.3 Global Infliximab and biosimilar Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Infliximab and biosimilar Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Infliximab and biosimilar Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Infliximab and biosimilar Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Infliximab and biosimilar Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Infliximab and biosimilar Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Infliximab and biosimilar Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Infliximab and biosimilar Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
4 Global Infliximab and biosimilar Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Infliximab and biosimilar Consumption by Region (2013-2018)
4.2 North America Infliximab and biosimilar Production, Consumption, Export, Import (2013-2018)
4.3 Europe Infliximab and biosimilar Production, Consumption, Export, Import (2013-2018)
4.4 China Infliximab and biosimilar Production, Consumption, Export, Import (2013-2018)
4.5 Japan Infliximab and biosimilar Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Infliximab and biosimilar Production, Consumption, Export, Import (2013-2018)
4.7 India Infliximab and biosimilar Production, Consumption, Export, Import (2013-2018)
5 Global Infliximab and biosimilar Production, Revenue (Value), Price Trend by Type
5.1 Global Infliximab and biosimilar Production and Market Share by Type (2013-2018)
5.2 Global Infliximab and biosimilar Revenue and Market Share by Type (2013-2018)
5.3 Global Infliximab and biosimilar Price by Type (2013-2018)
5.4 Global Infliximab and biosimilar Production Growth by Type (2013-2018)
6 Global Infliximab and biosimilar Market Analysis by Application
6.1 Global Infliximab and biosimilar Consumption and Market Share by Application (2013-2018)
6.2 Global Infliximab and biosimilar Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Infliximab and biosimilar Manufacturers Profiles/Analysis
7.1 Janssen Biotech
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Infliximab and biosimilar Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Janssen Biotech Infliximab and biosimilar Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Merck and Co.
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Infliximab and biosimilar Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Merck and Co. Infliximab and biosimilar Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Pfizer
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Infliximab and biosimilar Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Pfizer Infliximab and biosimilar Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
8 Infliximab and biosimilar Manufacturing Cost Analysis
8.1 Infliximab and biosimilar Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Infliximab and biosimilar
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Infliximab and biosimilar Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Infliximab and biosimilar Major Manufacturers in 2017
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Infliximab and biosimilar Market Forecast (2018-2025)
12.1 Global Infliximab and biosimilar Capacity, Production, Revenue Forecast (2018-2025)
12.1.1 Global Infliximab and biosimilar Capacity, Production and Growth Rate Forecast (2018-2025)
12.1.2 Global Infliximab and biosimilar Revenue and Growth Rate Forecast (2018-2025)
12.1.3 Global Infliximab and biosimilar Price and Trend Forecast (2018-2025)
12.2 Global Infliximab and biosimilar Production, Consumption , Import and Export Forecast by Region (2018-2025)
12.2.1 North America Infliximab and biosimilar Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.2 Europe Infliximab and biosimilar Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.3 China Infliximab and biosimilar Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.4 Japan Infliximab and biosimilar Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.5 Southeast Asia Infliximab and biosimilar Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.6 India Infliximab and biosimilar Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Infliximab and biosimilar Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Infliximab and biosimilar Consumption Forecast by Application (2018-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer